The Biotech Growth Trust PLC (BIOG.L)

GBp 770.0

(0.26%)

Market Cap (In GBp)

206.7 Million

Revenue (In GBp)

81.87 Million

Net Income (In GBp)

74.6 Million

Avg. Volume

131.91 Thousand

Currency
GBp
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
840.939-1109.47
PE
2.87
EPS
2.68
Beta Value
0.497
ISIN
GB0000385517
CUSIP
G1281H103
CIK
-
Shares
26844500.0
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Asset Management
CEO
Mr. Samuel David Isaly
Employee Count
-
Website
https://www.biotechgt.com/index.php/biog/home/overview/
Ipo Date
1997-06-23
Details
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.